21 May 2013
Keywords: viagene, starts, ifn, gamma, gene, trial, begun
Article | 03 July 1995
Viagene has begun a Phase I study of its interferon gamma
immunotherapeutic vector product for the treatment of various advanced
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 July 1995
26 June 1995
20 May 2013
© 2013 thepharmaletter.com